Evidence map›Paper›PMID 32644257›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2020

Control of blood pressure levels in patients with premature coronary artery disease: Results from the Genetics of Atherosclerotic Disease study.

Esteban Jorge-Galarza, Froylan D Martínez-Sánchez, Cesar I Javier-Montiel, Aida X Medina-Urrutia, Carlos Posadas-Romero, María C González-Salazar, Horacio Osorio-Alonso, Abraham S Arellano-Buendía, Juan G Juárez-Rojas

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Esteban Jorge-GalarzaDepartment of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Froylan D Martínez-SánchezDepartment of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID 0000-0002-2719-1105
Cesar I Javier-MontielDepartment of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID 0000-0001-5166-5027
Aida X Medina-UrrutiaDepartment of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Carlos Posadas-RomeroDepartment of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
María C González-SalazarDepartment of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Horacio Osorio-AlonsoDepartment of Cardio-Renal Physiopathology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Abraham S Arellano-BuendíaDepartment of Cardio-Renal Physiopathology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Juan G Juárez-RojasDepartment of Endocrinology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID 0000-0001-8864-2304
Instituto Nacional de Cardiología · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High blood pressure (BP) is the major cardiovascular-risk factor for coronary artery disease (CAD), principally in young patients who have an important and increasing socioeconomic burden. Despite the Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7), recommended BP target <140/90 mm Hg for patients with stable CAD, in 2017 the American College of Cardiology and the American Heart Association (ACC/AHA) updated BP target to <130/80 mm Hg. We aimed to analyze the prevalence of BP control in patients with premature CAD using both criteria. In addition, antihypertensive therapy, lifestyle, clinical, and sociodemographic characteristics of the patients were evaluated in order to identify factors associated with the achievement of BP targets. The present study included 1206 patients with CAD diagnosed before 55 and 65 years old in men and women, respectively. Sociodemographic, clinical, and biochemical data were collected. The results indicate that 85.6% and 77.5% of subjects with premature CAD achieved JNC-7 non-strict and ACC/AHA strict BP target, respectively. Consistently, number of antihypertensive drugs and hypertension duration >10 years were inversely associated with BP targets, whereas total physical activity and smoking were directly associated with BP targets, regardless of BP criteria. Considering that age, gender, and hypertension duration are non-modifiable cardiovascular-risk factors, our results highlight the need for more effective strategies focused on increase physical activity and smoking cessation in young patients with CAD. These healthier lifestyles changes should favor the BP target achievement and reduce the socioeconomic and clinical burden of premature CAD.

Indexed as

Coronary Artery DiseaseHypertensionAgedAmerican Heart AssociationAntihypertensive AgentsBlood PressureFemaleHumansMaleMiddle AgedUnited StatesAntihypertensive Agentsantihypertensive drugsblood pressurecardiovascular-risk factorshypertensionpremature coronary artery disease

Identifiers

PMID32644257
PMCPMC8029811
OpenAlexW3041908254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.